Company / Shareholders' Equity
VOLITIONRX LTD Shareholders' Equity History
FY2012-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Shareholders' Equity
-$34.2M
FY2025
5-year range
-$34.2M / $16.3M
FY2021-FY2025
Trend
-37.5%
vs FY2024
Sector context
Sector data unavailable
Latest sector comparison
What the data says
VOLITIONRX LTD reports negative total equity of -$34M in FY2025. Negative equity can occur when accumulated losses exceed contributed capital, as reported in the balance sheet from the SEC filing.
Based on SEC 10-K filings.
-$34M in FY2025.
Declined from -$8M to -$34M over the past 2 years.
Shareholders' Equity over time
Growth rates
- 3-Year CAGR
- -
- 5-Year CAGR
- -
- 10-Year CAGR
- -
Key checks
Key Insights
- VOLITIONRX LTD's shareholders' equity has declined for 4 consecutive years.
- In FY2025, shareholders' equity decreased 37.5% year-over-year.
- Peak shareholders' equity was recorded in FY2021.
Company context
Key Data Points
- Low Piotroski F-Score: 2/9 (multiple financial health concerns)
- Altman Z-Score -13.39 (distress zone, below 1.8 threshold)
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Shareholders' EquityValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | -$34.2M | -37.5% |
| FY2024 | -$24.9M | -219.2% |
| FY2023 | -$7.8M | -149.5% |
| FY2022 | -$3.1M | -119.2% |
| FY2021 | $16.3M | +14.8% |
| FY2020 | $14.2M | +17.0% |
| FY2019 | $12.1M | +1683.6% |
| FY2014 | $680.7K | -18.4% |
| FY2013 | $833.8K | -23.4% |
| FY2012 | $1.1M | - |
As of FY2025 · SEC 10-K · Updated Jun 24, 2026